Total number of projects: 3
As coordinator: 1
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0.5*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2011 | 0 | 2.498.680 | 2.498.680 | 1 | ||
2010 | 5.600.000 | 5.900.000 | 966.652 | 1 | 1 |
Total number of partners: 3896
Partner loyalty:
Frequent Partner: (> 2 projects): 2183
Rare Partner: 1713
Frequent / Rare Partner Ratio: 1.27
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2011-11-01 | Mimicking pathogens; an integrated nano-medicine approach to developing intelligent cancer vaccines | PATHFINDER | participant | 2.498.680 | 1 |
2010-05-01 | Paediatric European Risperidone Studies | PERS | coordinator | 5.600.000 | 21 |
2010-01-01 | European multicenter network to evaluate pharmacokinetics, safety and efficacy of Meropenem in neonatal sepsis and meningitis | NEOMERO | participant | 5.900.000 | 12 |